P/E ratio for VBI Vaccines (VBIV)
P/E ratio as of April 2025 (TTM): -0.0047
According to VBI Vaccines 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.00473298. At the end of 2022 the company had a P/E ratio of -0.8904.
P/E ratio history for VBI Vaccines from 2002 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.8904 | -89.73% |
| 2021 | -8.67 | -33.82% |
| 2020 | -13.1 | 327.02% |
| 2019 | -3.07 | 85.92% |
| 2018 | -1.65 | -66.01% |
| 2017 | -4.85 | 12.7% |
| 2016 | -4.31 | 1036.7% |
| 2015 | -0.3788 | -91.91% |
| 2014 | -4.68 | -51.11% |
| 2013 | -9.58 | 60.69% |
| 2012 | -5.96 | 78.12% |
| 2011 | -3.35 | -83.28% |
| 2010 | -20.0 | -49.3% |
| 2009 | -39.5 | -142.7% |
| 2008 | 92.5 | -130.58% |
| 2007 | -303 | 135.71% |
| 2006 | -128 | 742.76% |
| 2005 | -15.2 | -96.02% |
| 2004 | -382 | -25.41% |
| 2003 | -513 | 72520.16% |
| 2002 | -0.7059 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -0.9953 | 20,929.03% | 🇺🇸 USA |
 | -2.67 | 56,404.36% | 🇺🇸 USA |
 | -0.1230 | 2,498.79% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.